Acute Pain Management in Pediatric Dentistry

Board takeaway

1. Assess and treat the cause. Assess the child's pain and plan relief before treatment starts. Use reliable self-report when possible; for a child who cannot describe pain, combine a validated observational scale with caregiver information and the examination.
2. Choose relief. For mild to moderate acute postoperative pain, an NSAID is a first-line option when medically appropriate. Pair medication with reassurance and other supportive measures.
3. Prepare and reassess. Give clear caregiver instructions and reassess the response.

This policy establishes those priorities; the pain-management best practice develops the clinical choices.

Compare analgesic choices

Medication complements diagnosis, treatment of the cause, reassurance, and other supportive measures. Select an individualized plan and give caregivers instructions; this policy does not provide doses or a universal reassessment interval.

Prevention and assessment

• Infants, children, adolescents, and patients with special health care needs experience pain; responses vary substantially.
• Prevention, early disease intervention, and a dental home can prevent or substantially relieve dental pain. Anticipatory guidance supports prevention and timely access to care.
• Include pain assessment in the history and examination: location, quality, intensity, and aggravating or relieving factors.
• Favor self-report when the child can report reliably. Add caregiver observations and observational scales when developmental, cognitive, or communication limitations interfere.
• Use validated pediatric pain scales consistently to assess and evaluate pain; document findings clearly and objectively.
• Assessment guides diagnosis, treatment priorities, and analgesic needs. Undertreatment can have physical and psychological consequences and influence future pain experiences.

Individualized pain management

• Plan around medical history, psychological factors, trauma or infection severity, and procedure extent and duration.
• Combine pharmacologic and nonpharmacologic approaches when appropriate; combined care may improve comfort and treatment success.
• Supportive measures include a calm environment, emotional support, deep breathing, imagery, distraction, and play therapy.
• Other listed adjuncts include hypnotherapy, virtual reality, smartphone applications, acupuncture, and transcutaneous nerve stimulation. Listing does not establish equal effectiveness.
• Pharmacologic modalities span topical/local anesthesia, analgesics, sedation, and general anesthesia; this policy supplies no selection criteria or administration protocols for these modalities.

Analgesic choices and safety

• NSAID examples include ibuprofen and naproxen. Review medical contraindications before selecting an NSAID.
• Alternating or combining ibuprofen and acetaminophen may provide complementary benefit and permit lower doses. No universal alternating schedule is supplied.
• Oral, rectal, and intravenous routes accommodate different patients and settings; no route-specific regimen is given.
• NSAIDs may prolong bleeding and worsen kidney or liver impairment.
• Acetaminophen overuse can cause liver toxicity. Aspirin-containing products carry a risk of potentially fatal brain swelling with certain viral illnesses.
• Opioids may relieve severe pain but carry risks of nausea, vomiting, constipation, sedation, respiratory depression, diversion, and misuse. Persistent use is a particular pediatric concern.
• The policy cites a study associating approximately one in ten opioid-prescribed pediatric dental visits with subsequent overdose or persistent use, with greatest risk in younger children. This is a study association, not an individual risk prediction.
• FDA restrictions address codeine and tramadol in children and breastfeeding mothers. The separate age-18 restriction described here concerns codeine/hydrocodone cough medicines, not all dental analgesic prescribing.

Counseling, access, and evidence

• Give caregivers individualized information about pain-management options and adverse effects; follow current evidence-based prescribing recommendations.
• Support equitable access to medically necessary pain management.
• The update reviewed dental/medical literature, including a pediatric PubMed search; insufficient or inconclusive evidence was supplemented by expert or consensus opinion. No formal recommendation grades are provided.
• Research remains needed on effective nonpharmacologic techniques and safe pharmacologic administration routes. No fixed reassessment interval is specified.

Common board traps

Answer aloud

How do you assess pain in a child with limited communication?

Use an appropriate validated observational scale with caregiver information and the clinical examination.

• Assess location, quality, intensity, and aggravating or relieving factors.
• Favor self-report when reliable; limited communication does not mean limited pain.
• Document findings objectively and use the scale consistently to reassess response.

How do you plan mild to moderate postoperative dental pain relief for a child?

Use an NSAID as a first-line option when medically appropriate, alongside supportive measures and treatment of the cause.

• Individualize for medical and psychological factors, infection/trauma, and procedure extent and duration.
• Review bleeding and kidney/liver risks; acetaminophen overuse can cause hepatotoxicity.
• Combining or alternating ibuprofen and acetaminophen may help, but this policy supplies no universal alternating schedule.
• Give individualized caregiver instructions and reassess response. Use the pain-management best practice for clinical selection and the Useful Medications resource with current product information for reference dosing.

What opioid safety distinctions should you retain from the acute-pain policy?

Opioids carry respiratory, sedation, misuse, diversion, and persistent-use risks; their potential benefit for severe pain does not establish routine pediatric dental prescribing.

• FDA restrictions address codeine and tramadol in children and breastfeeding mothers.
• The separate age-18 restriction cited here concerns codeine/hydrocodone cough medicines.
• This policy does not supply opioid selection criteria or dosing.